Demeanor of rivaroxaban in activated/inactivated FXa.
Seki K, Mizuno Y, Sakashita T, Nakano S, Tanno J, Okazaki Y, Muramatsu T, Nishimura S, Senbonmatsu T.
Seki K, et al. Among authors: nakano s.
J Pharmacol Sci. 2017 Mar;133(3):156-161. doi: 10.1016/j.jphs.2017.02.010. Epub 2017 Feb 24.
J Pharmacol Sci. 2017.
PMID: 28314697
Free article.